Propping open clogged heart arteries with a "disappearing stent" has worked well for three years in the first people implanted with the unique device, according to research presented at the American Heart Association's Scientific Sessions 2013.
The new bioabsorbable magnesium stent (DREAMS) is a drug-releasing tube that is reabsorbed over time, leaving behind a healthy vessel and reducing clotting that sometimes occurs 12-24 months after implantation of a traditional drug-coated stent.
Of 46 people implanted with the stent, the failure rate was 6.8 percent, with two patients requiring vessel-opening procedures and one suffering a heart attack during angiography one year after receiving the stent.
During the second year, no patient had a heart attack, heart-related death or developed a blood clot within the stent. Various imaging techniques confirmed that the stents were being absorbed as planned.
For more news from AHA Scientific Sessions 2013 follow us on Twitter @HeartNews #AHA13.
Statements and conclusions of study authors that are presented at American Heart Association scientific meetings are solely those of the study authors and do not necessarily reflect association policy or position. The association makes no representation or warranty as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at http://www.
Additional resources related to these tips are on the right column of the release link at http://newsroom.
NOTE: ALL TIMES ARE CENTRAL. ALL TIPS ARE EMBARGOED UNTIL THE TIME OF PRESENTATION OR 3 P.M. CT/4 PM ET EACH DAY, WHICHEVER COMES FIRST. For more information Nov. 16-20, call the AHA News Media Staff Office in the Dallas Convention Center at (214) 853-8008. Before or after these dates, call the Communications Office in Dallas at (214) 706-1173. For public inquiries, call (800) AHA-USA1 (242-8721).